These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 33257571)

  • 41. Effect of insulin on farnesyltransferase activity in 3T3-L1 adipocytes.
    Goalstone ML; Draznin B
    J Biol Chem; 1996 Nov; 271(44):27585-9. PubMed ID: 8910345
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Combining prenylation inhibitors causes synergistic cytotoxicity, apoptosis and disruption of RAS-to-MAP kinase signalling in multiple myeloma cells.
    Morgan MA; Sebil T; Aydilek E; Peest D; Ganser A; Reuter CW
    Br J Haematol; 2005 Sep; 130(6):912-25. PubMed ID: 16156861
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Caged protein prenyltransferase substrates: tools for understanding protein prenylation.
    DeGraw AJ; Hast MA; Xu J; Mullen D; Beese LS; Barany G; Distefano MD
    Chem Biol Drug Des; 2008 Sep; 72(3):171-81. PubMed ID: 18844669
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CaaX-prenyltransferases are essential for expression of genes involvedin the early stages of monoterpenoid biosynthetic pathway in Catharanthus roseus cells.
    Courdavault V; Thiersault M; Courtois M; Gantet P; Oudin A; Doireau P; St-Pierre B; Giglioli-Guivarc'h N
    Plant Mol Biol; 2005 Apr; 57(6):855-70. PubMed ID: 15952070
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ras protein farnesyltransferase: A strategic target for anticancer therapeutic development.
    Rowinsky EK; Windle JJ; Von Hoff DD
    J Clin Oncol; 1999 Nov; 17(11):3631-52. PubMed ID: 10550163
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Low SAFB levels are associated with worse outcome in breast cancer patients.
    Hammerich-Hille S; Bardout VJ; Hilsenbeck SG; Osborne CK; Oesterreich S
    Breast Cancer Res Treat; 2010 Jun; 121(2):503-9. PubMed ID: 19137425
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Scaffold attachment factor B: distribution and interaction with ERĪ± in the rat brain.
    Hashimoto T; Kawata M; Hirahara Y; Nishi M; Satoshi I; Matsuda KI
    Histochem Cell Biol; 2020 May; 153(5):323-338. PubMed ID: 32086573
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of Ras prenylation: a signaling target for novel anti-cancer drug design.
    Lerner EC; Hamilton AD; Sebti SM
    Anticancer Drug Des; 1997 Jun; 12(4):229-38. PubMed ID: 9199657
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Protein farnesyltransferase inhibitors.
    Ayral-Kaloustian S; Salaski EJ
    Curr Med Chem; 2002 May; 9(10):1003-32. PubMed ID: 12733981
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A farnesyl-protein transferase inhibitor induces p21 expression and G1 block in p53 wild type tumor cells.
    Sepp-Lorenzino L; Rosen N
    J Biol Chem; 1998 Aug; 273(32):20243-51. PubMed ID: 9685373
    [TBL] [Abstract][Full Text] [Related]  

  • 51. GTP loading of farnesylated p21Ras by insulin at the plasma membrane.
    Goalstone M; Leitner JW; Draznin B
    Biochem Biophys Res Commun; 1997 Oct; 239(1):42-5. PubMed ID: 9345266
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Protein prenylation: a mediator of protein-protein interactions.
    Marshall CJ
    Science; 1993 Mar; 259(5103):1865-6. PubMed ID: 8456312
    [No Abstract]   [Full Text] [Related]  

  • 53. Bisubstrate inhibitors of farnesyltransferase: a novel class of specific inhibitors of ras transformed cells.
    Manne V; Yan N; Carboni JM; Tuomari AV; Ricca CS; Brown JG; Andahazy ML; Schmidt RJ; Patel D; Zahler R
    Oncogene; 1995 May; 10(9):1763-79. PubMed ID: 7753553
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A SNARE geranylgeranyltransferase essential for the organization of the Golgi apparatus.
    Shirakawa R; Goto-Ito S; Goto K; Wakayama S; Kubo H; Sakata N; Trinh DA; Yamagata A; Sato Y; Masumoto H; Cheng J; Fujimoto T; Fukai S; Horiuchi H
    EMBO J; 2020 Apr; 39(8):e104120. PubMed ID: 32128853
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Protection against malignant conversion in SENCAR mouse skin by all trans retinoic acid: inhibition of the ras p21-processing enzyme farnesyltransferase and Ha-ras p21 membrane localization.
    Agarwal R; Mohan RR; Ahmad N; Mukhtar H
    Mol Carcinog; 1996 Sep; 17(1):13-22. PubMed ID: 8876671
    [TBL] [Abstract][Full Text] [Related]  

  • 56. SAFB1- and SAFB2-mediated transcriptional repression: relevance to cancer.
    Hong EA; Gautrey HL; Elliott DJ; Tyson-Capper AJ
    Biochem Soc Trans; 2012 Aug; 40(4):826-30. PubMed ID: 22817742
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Conversion of protein farnesyltransferase to a geranylgeranyltransferase.
    Terry KL; Casey PJ; Beese LS
    Biochemistry; 2006 Aug; 45(32):9746-55. PubMed ID: 16893176
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High-performance liquid chromatography/mass spectrometry characterization of Ki4B-Ras in PSN-1 cells treated with the prenyltransferase inhibitor L-778,123.
    Buser CA; Dinsmore CJ; Fernandes C; Greenberg I; Hamilton K; Mosser SD; Walsh ES; Williams TM; Koblan KS
    Anal Biochem; 2001 Mar; 290(1):126-37. PubMed ID: 11180946
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibitors of farnesyl protein transferase and MEK1,2 induce apoptosis in fibroblasts transformed with farnesylated but not geranylgeranylated H-Ras.
    Brassard DL; English JM; Malkowski M; Kirschmeier P; Nagabhushan TL; Bishop WR
    Exp Cell Res; 2002 Feb; 273(2):138-46. PubMed ID: 11822869
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Protein farnesyltransferase and geranylgeranyltransferase share a common alpha subunit.
    Seabra MC; Reiss Y; Casey PJ; Brown MS; Goldstein JL
    Cell; 1991 May; 65(3):429-34. PubMed ID: 2018975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.